Educational Events & Programs
NCCN CME/CE Programs
Earn CME/CE credit with our online, interactive learning center. Access free, continuing education activities.
NCCN CME/CE Programs include presentation webcasts, streaming videos, podcasts, and an audio library of presentations from the NCCN Annual Conference, and Annual Congresses.
NCCN CME/CE Programs also include JNCCN Task Force Supplements*, for which NCCN convenes experts from within and beyond NCCN Member Institutions to expand on issues discussed in the NCCN Guidelines and to discuss issues outside the scope of the NCCN Guidelines.
NCCN CME/CE Programs are approved for AMA PRA Category 1 Credit™ and are also approved for nursing contact hours. (Note: Streaming videos are not approved for CME/CE credit.)
NCCN CME/CE Programs are free for registered users. Please note that you will need to complete an additional registration to access the webcasts. We apologize for any inconvenience.
Acute Myeloid Leukemia
- Epigenetic Modulation in Hematologic Malignancies: Challenges and Progress (Text Article)
Bladder Cancer
- NCCN Task Force Report: Clinical Utility of PET in a Variety of Tumor Types (JNCCN Supplement)
Breast Cancer
- Adjuvant Bisphosphonate Therapy for Patients With Breast Cancer (Webcast)
- Advances in the Use of Aromatase Inhibitors in the Treatment of Breast Cancer (Webcast | CD-ROM | Podcast/MP3 | Podcast Evaluation)
- Controversies in Cancer Screening (Webcast)
- Metastatic Breast Cancer: Individualizing Treatment (Webcast)
- NCCN Clinical Practice Guidelines in Oncology Symposium: Breast Cancer (Webcast)
- NCCN – MedscapeCME Oncology Breast Cancer Tumor Board (Webcast)
- NCCN Risk-Based Breast Cancer Screening Guidelines (Webcast) This activity is not approved for CME/CE credits.
- NCCN Task Force Report: Adjuvant Therapy for Breast Cancer (JNCCN Supplement*)
- NCCN Task Force Report: Breast Cancer in the Older Woman (JNCCN Supplement*)
- NCCN Task Force Report: HER2 Testing in Breast Cancer (JNCCN Supplement*)
- NCCN Task Force Report: Integration of ER/PR Tumor Markers into Treatment Planning for Breast Cancer (Webcast | CD-ROM | Podcast/MP3 | Podcast Evaluation)
- NCCN Task Force Report: mTOR Inhibition in Solid Tumors (JNCCN Supplement*)
- NCCN Task Force Report: PET/CT Scanning in Cancer (JNCCN Supplement*)
- New Advances in Risk Reduction for Recurrence of Breast Cancer in Premenopausal Women (Webcast | CD-ROM | Podcast/MP3 | Podcast Evaluation)
- Sequencing of Hormonal Therapy in Metastatic Breast Cancer (Webcast)
Central Nervous System Cancers
- NCCN Task Force Report: Clinical Utility of PET in a Variety of Tumor Types (JNCCN Supplement)
Cervical Cancer
- NCCN Task Force Report: Clinical Utility of PET in a Variety of Tumor Types (JNCCN Supplement)
Chronic Myelogenous Leukemia
Colon/Rectal/Anal Cancers
Esophageal Cancer
- NCCN Task Force Report: Clinical Utility of PET in a Variety of Tumor Types (JNCCN Supplement)
Gastric Cancer
- NCCN Task Force Report: Clinical Utility of PET in a Variety of Tumor Types (JNCCN Supplement)
Head and Neck Cancers
Healthcare Policy and Practice
- Fostering Multidisciplinary Cancer Care in a Community Setting (Streaming Video)
- Roundtable Discussion – Finding and Achieving Value in Cancer Care (Streaming Video)
Hepatobiliary Cancers
- NCCN Task Force Report: Clinical Utility of PET in a Variety of Tumor Types (JNCCN Supplement)
- NCCN Task Force Report: mTOR Inhibition in Solid Tumors (JNCCN Supplement*)
Kidney Cancer
Multiple Myeloma
Neuroendocrine Tumors
Non-Hodgkin’s Lymphomas
Non-Small Cell Lung Cancer
- Controversies in Cancer Screening (Webcast)
- Living with Advanced Non-Small Cell Lung Cancer (Webcast | DVD)
- NCCN-MedscapeCME Oncology: Non-Small Cell Lung Cancer Tumor Board (Webcast)
- NCCN Clinical Practice Guidelines in Oncology Symposium: Non-Small Cell Lung Cancer (Webcast)
- NCCN Task Force Report: mTOR Inhibition in Solid Tumors (JNCCN Supplement*)
- NCCN Task Force Report: PET/CT Scanning in Cancer (JNCCN Supplement*)
- New Advances in the First-Line Treatment of Non-Small Cell Lung Cancer (Webcast | CD-ROM | Podcast/MP3 | Podcast Evaluation)
Ovarian Cancer
- Controversies in Cancer Screening (Webcast)
- NCCN Task Force Report: Clinical Utility of PET in a Variety of Tumor Types (JNCCN Supplement)
- NCCN Task Force Report: mTOR Inhibition in Solid Tumors (JNCCN Supplement*)
Pancreatic Adenocarcinoma
- NCCN Task Force Report: Clinical Utility of PET in a Variety of Tumor Types (JNCCN Supplement)
Patient/Physician Communication
PET/CT Scanning
- NCCN Task Force Report: Clinical Utility of PET in a Variety of Tumor Types (JNCCN Supplement)
- NCCN Task Force Report: PET/CT Scanning in Cancer (JNCCN Supplement*)
Prostate Cancer
- Management of Advanced Prostate Cancer (Webcast)
- NCCN Task Force Report: Clinical Utility of PET in a Variety of Tumor Types (JNCCN Supplement)
- NCCN Task Force Report: mTOR Inhibition in Solid Tumors (JNCCN Supplement*)
Small Cell Lung Cancer
- NCCN Task Force Report: Clinical Utility of PET in a Variety of Tumor Types (JNCCN Supplement)
Soft Tissue Sarcoma
- NCCN Task Force Report: Clinical Utility of PET in a Variety of Tumor Types (JNCCN Supplement)
- NCCN Task Force Report: Gastrointestinal Stromal Tumors (GIST) (JNCCN Supplement)
Supportive Care
Survivorship
- Roundtable Discussion – Cancer as a Chronic Disease: What Should be Done to Serve Cancer Survivors in 2009 and Beyond? (Streaming Video)
Thyroid Carcinoma
- NCCN Task Force Report: Clinical Utility of PET in a Variety of Tumor Types (JNCCN Supplement)
Uterine Neoplasms
- NCCN Task Force Report: Clinical Utility of PET in a Variety of Tumor Types (JNCCN Supplement)
- NCCN Task Force Report: mTOR Inhibition in Solid Tumors (JNCCN Supplement*)
* Please see individual task force report for more information on CME/CE credits.
These files are for individual use only; printing out multiple copies is strictly prohibited. You may not reproduce and/or distribute any file in other formats or media or for any other purposes. For multiple copies/reprints, please contact David Horowitz.
Each JNCCN supplement is copyrighted by the National Comprehensive Cancer Network. All rights reserved. This file may not be used for any other purposes without further permission from the National Comprehensive Cancer Network. Permission can be requested at here.
You are not permitted to translate, reformat, add to, rearrange, delete pages, extract portions, modify, adapt, or change any parts of this file without further permission from the National Comprehensive Cancer Network. You are not permitted to place advertisements or logos of any kind on or within this file. You are not permitted to distribute this file electronically (including via internet, CD-ROM, PDA, DVD, etc...).